Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

Market Cap	44.79B
Revenue (ttm)	4.64B
Net Income (ttm)	1.84B
Shares Out	785.72M
EPS (ttm)	2.34
PE Ratio	24.35
Forward PE	21.49
Dividend	1.30 (2.24%)
Ex-Dividend Date	May 28, 2025

Volume	1,539,200
Average Volume	4,747,406
Open	58.76
Previous Close	57.01
Day's Range	56.61 - 58.76
52-Week Range	49.01 - 97.20
Beta	-0.45
RSI	43.45
Earnings Date	Aug 22, 2025

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,841
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2024, SHE:300832's revenue was 4.54 billion, an increase of 15.41% compared to the previous year's 3.93 billion. Earnings were 1.83 billion, an increase of 10.57%.